VYN201 gel being evaluated in subjects with nonsegmental vitiligoTop-line data from the 24-week double-blind portion of the trial expected in mid-2025"Repibresib" approved as the non-proprietary ...
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Medical Aesthetics Market offers comprehensive insights into the market landscape, customer ...